Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trebst

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Brain : a Journal of Neurology|July 18, 2024
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulationTilman Schneider-Hohendorf, Christian Wünsch, Simon Falk, et al.
Neurology|July 2, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort StudyDaniel Engels, Patrick Schindler, Joachim Havla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 23, 2018
Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventionsIngo Kleiter, Anna Gahlen, Nadja Borisow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 3, 2017
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of responseJan-Patrick Stellmann, Markus Krumbholz, Tim Friede, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2024
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacksCarolin Schwake, Theodoros Ladopoulos, Vivien Häußler, et al.
Annals of Neurology|November 6, 2015
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment coursesIngo Kleiter, Anna Gahlen, Nadja Borisow, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2016
Influence of female sex and fertile age on neuromyelitis optica spectrum disordersNadja Borisow, Ingo Kleiter, Anna Gahlen, et al.
Journal of Neurology|December 21, 2024
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and visionMihaela Nicolescu, Vivien Häußler, Friedemann Paul, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 27, 2024
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGADVivien Häußler, Corinna Trebst, Daniel Engels, et al.
Neurology|October 1, 2024
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European CohortMarius Ringelstein, Susanna Asseyer, Gero Lindenblatt, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Brain : a Journal of Neurology|July 18, 2024
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulationTilman Schneider-Hohendorf, Christian Wünsch, Simon Falk, et al.
Neurology|July 2, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort StudyDaniel Engels, Patrick Schindler, Joachim Havla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 23, 2018
Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventionsIngo Kleiter, Anna Gahlen, Nadja Borisow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 3, 2017
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of responseJan-Patrick Stellmann, Markus Krumbholz, Tim Friede, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2024
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacksCarolin Schwake, Theodoros Ladopoulos, Vivien Häußler, et al.
Annals of Neurology|November 6, 2015
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment coursesIngo Kleiter, Anna Gahlen, Nadja Borisow, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 21, 2016
Influence of female sex and fertile age on neuromyelitis optica spectrum disordersNadja Borisow, Ingo Kleiter, Anna Gahlen, et al.
Journal of Neurology|December 21, 2024
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and visionMihaela Nicolescu, Vivien Häußler, Friedemann Paul, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 27, 2024
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGADVivien Häußler, Corinna Trebst, Daniel Engels, et al.
Neurology|October 1, 2024
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European CohortMarius Ringelstein, Susanna Asseyer, Gero Lindenblatt, et al.
Pageof 20